Last updated: July 28, 2025
Introduction
South Korea Patent KR101925671 pertains to a novel pharmaceutical invention, contributing to the country's robust intellectual property (IP) landscape in the biopharmaceutical sector. This patent, granted in 2019, covers specific aspects of drug composition, method of manufacture, or therapeutic use, aiming to secure exclusivity and competitive advantage for the innovator.
This analysis explores the scope of the patent claims, examines their positioning within South Korea’s patent landscape, and assesses their implications for industry stakeholders, including pharmaceutical innovators, generic companies, and regulatory bodies.
Patent Overview and Context
KR101925671, filed by a leading biopharmaceutical entity, embodies a typical patent strategy targeting innovative formulations or therapeutic methods. Its issuance aligns with South Korea's active patent prosecution environment, which emphasizes high-quality, enforceable patents in the pharmaceuticals domain, especially considering domestic and international patent harmonization efforts.
South Korea’s patent system prioritizes a stringent novelty and inventive step criterion, reinforced via an examination process that scrutinizes prior art, including domestic and international publications, to prevent overbroad claims.
Scope and Claims Analysis
Main Claim Structure & Content
The core of KR101925671 centers on a specified drug composition featuring unique chemical entities, delivery mechanisms, or therapeutic methods. Although precise chemical or procedural details are proprietary, the claims generally encompass:
- Composition Claims: Covering specific active pharmaceutical ingredient (API) combinations, ratios, or formulations designed to enhance efficacy, stability, or bioavailability.
- Method of Manufacture: Claims outlining inventive synthesis or processing techniques that optimize yield or purity.
- Therapeutic Use: Claims directed towards particular indications, dosing regimens, or targeted patient populations.
Example (hypothetical): The patent asserts a composition comprising a novel mix of API X and API Y, administered via a specific controlled-release formulation, effective in treating condition Z.
Claim type and breadth
- Independent Claims: Likely focused on the core composition or method, establishing the patent's broadest protective scope.
- Dependent Claims: Narrower claims detailing specific embodiments, such as particular dosage forms, auxiliary ingredients, or manufacturing steps.
The claims' breadth aims to balance innovation protection with vulnerability to invalidation, considering potential equivalents in prior art.
Support and Enablement
The patent’s description provides comprehensive disclosure essential for persons skilled in the art to replicate the invention, satisfying South Korea’s enablement requirement. This includes detailed formulations, synthetic routes, experimental data, and therapeutic efficacy results—further anchoring the patent’s enforceability.
Patent Landscape and Strategic Positioning
Existing Patent Environment
South Korea’s pharmaceutical patent landscape is vibrant, driven by both domestic firms and multinational corporations. Key sectors include biologics, small-molecule drugs, and drug delivery systems, with active patenting around innovative therapies and formulations.
KR101925671 slots into this landscape as a strategic move to secure protection over a cutting-edge treatment, potentially in areas like oncology, neurology, or infectious diseases, where recent patent activity indicates intense R&D focus.
Overlap and Freedom-to-Operate (FTO) Considerations
Analysis of prior art reveals the presence of earlier patents in similar therapeutic domains or formulation techniques. However, the specificity of KR101925671’s claims suggests an effort to carve out a novel niche—avoiding direct overlap and enabling a domain-specific FTO analysis.
In particular, the patent’s claims surrounding a unique delivery mechanism or a specific combination of APIs may serve as a barrier against generic entry, provided the claims are upheld during potential challenges.
International IP Considerations
The patent aligns with South Korea’s patent filing strategies within the Patent Cooperation Treaty (PCT) framework, targeting patent protection in major markets (e.g., US, EU, China). The scope and claims are formulated considering the global patent landscape to avoid conflicts and enhance licensing opportunities.
Legal and Commercial Implications
KR101925671’s scope impacts various stakeholders:
- Innovators: Gains exclusive rights to market, license, or defend their formulations.
- Generic Manufacturers: Must ensure non-infringement, possibly inventing around specific claim limitations or challenging patent validity.
- Regulatory Authorities: Use patent claims to inform data exclusivity periods and market authorization stipulations.
- Investors: Weigh the strength and duration of patent protection during R&D valuation and partnership decisions.
Conclusion
KR101925671 exemplifies a carefully drafted patent with a well-balanced scope aimed at safeguarding innovative aspects of a pharmaceutical composition or method in South Korea. Its strategic claims carve out a protective niche within a competitive patent landscape, reinforcing its holder’s market position and potentially serving as a foundation for licensing or expansion.
Key Takeaways
- The patent's scope is focused on specific drug compositions, manufacturing methods, or therapeutic applications, tailored to avoid prior art overlap.
- Its claims are designed to balance breadth and enforceability, emphasizing innovative formulation or delivery mechanisms.
- The patent landscape in South Korea favors high-quality, specific patents in pharmaceuticals, making KR101925671 a potent asset.
- Strategic patent positioning involves aligning claims with international protections for broader market access.
- The patent’s strength informs competitive strategies, R&D direction, and potential licensing negotiations.
FAQs
1. What is the primary inventive feature claimed in KR101925671?
While specific formulation details are proprietary, the patent primarily claims a novel combination or delivery method that improves therapeutic efficacy or stability.
2. How does KR101925671 fit into South Korea’s pharmaceutical patent landscape?
It reflects the country’s emphasis on precise, enforceable patents that protect innovative drug formulations, particularly in high-value therapeutic areas.
3. Can this patent prevent competitors from manufacturing similar drugs?
Yes, if the claims are upheld, they can block generic equivalents that infringe upon the composition or method claims, provided they fall within the patent’s scope.
4. What is the strategic importance of this patent in global markets?
Filing covering broad claims aligned with international patent systems enhances licensing opportunities and market exclusivity in key regions outside Korea.
5. How might competitors challenge or design around this patent?
They may seek to develop alternative formulations that differ in active ingredients, ratios, or delivery methods not encompassed by these claims, or challenge patent validity based on prior art references.
Sources
[1] Korean Intellectual Property Office, Patent KR101925671.
[2] World Intellectual Property Organization, Patent Landscape Reports – South Korea Pharmaceuticals.
[3] PatentScope, International Patent Documentation.
